Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
Mucormycotic infections caused by fungi of the families Rhizopus, Mucor or Absidia are rare and usually associated with diabetes or immunosuppression. We describe a patient with invasive necrotizing cutaneous mucormycosis caused by Absidia corymbifera shortly after allogeneic BMT. The infection was successfully treated with surgical debridement and liposomal amphotericin B for 6 weeks. Recognition of these rare infections requires a high index of suspicion. These patients should be evaluated with tissue biopsy and cultures and treated without delay.
Jantunen
E
E
Department of Medicine, Kuopio University Hospital, Finland.
Kolho
E
E
Ruutu
P
P
Koukila-Kähkölä
P
P
Virolainen
M
M
Juvonen
E
E
Volin
L
L
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000753:Anemia, Refractory / Q000628:therapy*; D000935:Antifungal Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003646:Debridement; D003881:Dermatomycoses / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D009090:Mucorales / Q000302:isolation & purification*; D009091:Mucormycosis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology / Q000601:surgery
D000935:Antifungal Agents; D000666:Amphotericin B